ArticleAsian Pacific journal of cancer prevention : APJCP2025
The Role of Fibroblast Growth Factor Receptor 2 as A Prognostic Biomarker in Colorectal Adenocarcinoma.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to analyze the correlation between fibroblast growth factor receptor 2 (FGFR2) expression with the histopathological grade, tumor budding grade, lymphovascular invasion, and lymph node metastasis in colorectal adenocarcinoma.
methodsThis study used a cross-sectional design. Immunohistochemistry was performed on one hundred slides from paraffin-embedded blocks of colorectal adenocarcinoma using FGFR2 rabbit polyclonal antibody (E-AB-60590, Elabscience). FGFR2 expression was then assessed using an Olympus CX43 light microscope. Correlations between FGFR2 expression and histopathological grade, tumor budding grade, lymphovascular invasion, and lymph node metastasis of colorectal adenocarcinoma were statistically analyzed using Chi-square, Mann Whitney, and Kruskal Wallis tests with SPSS 27.
resultOf the 100 samples analyzed, high-grade tumor budding was the most common (n=56), of which 25% showed weak expression and 75% showed strong expression. In the positive lymphovascular invasion group (n=28), 89.3% showed strong expression, and 10.7% showed weak expression. In the positive lymph node metastasis group (n=32), 87.5% showed strong expression, and 12.5% showed weak expression. Based on the Chi-square test, FGFR2 expression was significantly correlated with the tumor budding grade (p = 0.017), lymphovascular invasion (p=0.003), and lymph node metastasis (p = 0.003). Still, there was no significant correlation with histopathological grade (p = 0.127) of colorectal adenocarcinoma.
conclusionFGFR2 expression may be an important prognostic biomarker in colorectal adenocarcinoma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.